Free Trial

Willow Biosciences (WLLW) Insider Trading & Ownership

Willow Biosciences logo
C$0.17 0.00 (0.00%)
As of 08/22/2025

Willow Biosciences (TSE:WLLW) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.34%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
C$26.11K
Number Of
Insiders Selling
(Last 3 Years)
0
Get WLLW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Willow Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WLLW Insider Buying and Selling by Quarter

Willow Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2024Travis DoupeSenior OfficerBuy49,500C$0.09C$4,207.50
11/29/2023Christopher Kenneth SavileDirectorBuy50,000C$0.08C$3,750.00
11/11/2022Peter Seufer-WasserthalDirectorBuy100,000C$0.14C$13,500.00
9/9/2022Christopher Kenneth SavileSenior OfficerBuy30,000C$0.16C$4,650.00
(Data available from 1/1/2013 forward)

WLLW Insider Trading Activity - Frequently Asked Questions

The list of insiders at Willow Biosciences includes Christopher Kenneth Savile, Peter Seufer-Wasserthal, and Travis Doupe. Learn more on insiders at WLLW.

24.34% of Willow Biosciences stock is owned by insiders. Learn more on WLLW's insider holdings.

The following insiders have purchased WLLW shares in the last 24 months: Christopher Kenneth Savile (C$3,750.00), and Travis Doupe (C$4,207.50).

Insiders have purchased a total of 99,500 WLLW shares in the last 24 months for a total of C$7,957.50 bought.

Willow Biosciences Key Executives

  • Dr. Chris Savile
    President, Director & CEO
  • Mr. Travis Doupe (Age 52)
    Chief Financial Officer
    Compensation: $378.12k
  • Dr. Trish Choudhary
    Senior Vice President of Research & Development
  • Mr. Troy T. Talkkari
    Vice President of Corporate Development
  • Mr. Sanjib Singh Gill L.L.B. (Age 48)
    Corporate Secretary


This page (TSE:WLLW) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners